← Leaderboards
Christopher A. Gaiteri
Rush University Medical Center
$12,822,587
Attributed
$19,954,382
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,954,382 · 5
By mechanism
R01$16,125,215 · 4
U01$3,829,167 · 1
Top collaborators
- Jeremy H. Herskowitz6 shared
- Nicholas Thomas Seyfried6 shared
- Xiaoqian Jiang3 shared
- Zhongming Zhao3 shared
- Albert Tzongyang Higgins-Chen1 shared
- Christopher H Van Dyck1 shared
Most similar at Rush University Medical Center
Same institution · by research overlap
- David A Bennett$145,760,843
- Julie A Schneider$29,310,501
- Elliott Jay Mufson$26,194,959
- Sue E. Leurgans$7,315,545
- Patricia A Boyle$20,473,928
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposMolecularImpaired CognitionSystems BiologyAgingS DiseaseBrain RegionBrainLinkPhenotypeAutopsyPathologyMemoryResilienceDementiaAffectInnovationCognitivePathologicCognitionBaseAutomobile DrivingProteinsProteome
Grant awards (22)
AIM-AI: an Actionable, Integrated and Multiscale genetic map of Alzheimer's disease via deep learning$1,259,982
U01 · FY2025 · AG
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease$800,351
R01 · FY2025 · AG
AIM-AI: an Actionable, Integrated and Multiscale genetic map of Alzheimer's disease via deep learning$1,291,066
U01 · FY2024 · AG
AIM-AI: an Actionable, Integrated and Multiscale genetic map of Alzheimer's disease via deep learning$1,278,119
U01 · FY2023 · AG
Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines$1,130,011
R01 · FY2023 · AG · contact PI
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease$1,050,306
R01 · FY2022 · AG
Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines$499,005
R01 · FY2022 · AG · contact PI
Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines$477,206
R01 · FY2022 · AG · contact PI
Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines$1,091,431
R01 · FY2021 · AG · contact PI
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease$1,079,457
R01 · FY2021 · AG
Molecular Networks Underlying Resilience to Alzheimer's Disease Among APOE E4 Carriers$761,628
R01 · FY2021 · AG
Identifying the molecular systems, networks, and key molecules that underlie cognitive resilience$437,163
R01 · FY2021 · AG · contact PI
Identifying the molecular systems, networks, and key molecules that underlie cognitive resilience$224,880
R01 · FY2021 · AG · contact PI
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease$1,019,854
R01 · FY2020 · AG
Identifying the molecular systems, networks, and key molecules that underlie cognitive resilience$662,043
R01 · FY2020 · AG · contact PI
Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines$1,120,761
R01 · FY2019 · AG · contact PI
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease$1,037,676
R01 · FY2019 · AG
Identifying the molecular systems, networks, and key molecules that underlie cognitive resilience$672,964
R01 · FY2019 · AG · contact PI
Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines$1,162,409
R01 · FY2018 · AG · contact PI
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease$1,119,254
R01 · FY2018 · AG
Identifying the molecular systems, networks, and key molecules that underlie cognitive resilience$860,867
R01 · FY2018 · AG · contact PI
Identifying the molecular systems, networks, and key molecules that underlie cognitive resilience$917,949
R01 · FY2017 · AG · contact PI